Global Healthcare Advisors’ M&A Database


Our proprietary platform provides market intelligence on M&A deals, notable developments and regulatory changes pertinent to our clients.

Search by company, filter by vertical (for data beginning in January 2019), or just browse to see the latest news, updated daily.

Have a lead on a great M&A deal you’d like to share with us? Submit a deal.

Question? Contact us at research@ghadvisors.net.

Showing results 1 through 50 of 12538

Website
Vertical
Category
QTR
Year
Summary
Home Health & Hospice
Deal
Q1
2021
BrightSpring Health Services has purchased Abode Healthcare from Summit Partners with a reported valuation of $775 million, PE Hub reported. The transaction is projected to bring the combined company roughly $6 billion in annual revenue. Louisville, -based BrightSpring’s total value currently rests at approximately $10 billion. Brightspring is a portfolio company of the global investment and private equity firm KKR & Co., which purchased the company in 2018 for approximately $1.32 billion. Currently awaiting regulatory approval, the acquisition of Durango, Colo.-based Abode Healthcare will “significantly deepen” BrightSpring’s hospice, palliative and clinical home health care segments, according to PE Hub sources.
Home Health & Hospice
Deal
Q1
2021
Brookdale Senior Living Inc. (NYSE: BKD) has agreed to sell a majority stake in its hospice, home health and outpatient therapy business to HCA Healthcare (NYSE: HCA). Brookdale will sell 80% of the equity in its health services segment to HCA for a purchase price of $400 million. Brookdale in December indicated that it would consider a sale or spin off of its health care services segment, after taking a series of financial punches from the coronavirus pandemic. Brookdale will retain a 20% equity interest in the venture with HCA Healthcare.
Behavioral Health
Deal
Q1
2021
LEARN Behavioral, which specializes in the tailored treatment of children and young adults with autism based on contemporary, family-focused Applied Behavior Analysis (ABA) therapy, announced the acquisition of the Behavior Analysis Center for Autism (BACA)—a highly respected provider of ABA services to the autism community throughout Indiana. BACA was co-founded by Carl Sundberg, Ph.D., BCBA-D, who studied under the late Jack L. Michael, Ph.D., a former psychologist and professor at Western Michigan University who is widely regarded as a seminal figure in the development of ABA therapy.
Ophthalmology
Deal
Q1
2021
EyeSouth Partners (“EyeSouth” or the “Company”) is pleased to announce that it has completed an affiliation with North Georgia Eye Clinic (“NGEC”). The affiliation represents EyeSouth’s ninth in the state of Georgia and twenty-second affiliation overall. EyeSouth is an eye care-focused management services organization backed by Shore Capital Partners. North Georgia Eye Clinic is led by Dr. L. Jeff Payne and Dr. Matthew Kaufman and functions with 10 total providers. NGEC employs approximately 75 support staff across six primary clinical locations in the North Georgia area.
Healthcare Staffing & Education
Deal
Q1
2021
Cornell Capital LLC ("Cornell Capital") and Trilantic North America, two leading private investment firms, announced Wednesday that they have agreed to acquire Fastaff Travel Nursing® ("Fastaff") and U.S. Nursing Corporation® ("U.S. Nursing"). This acquisition is part of a broader effort by Cornell Capital and Trilantic North America to build a leading tech-enabled platform for healthcare staffing, following three other recently announced acquisitions in the space. Founded in 1989, Fastaff and U.S. Nursing have provided hospitals with staffing solutions for more than three decades.
Contract Research Organizations
Deal
Q1
2021
Veristat, a scientific-minded, global clinical research organization (CRO), announced today the expansion of its biometrics capacities and European team by acquiring SQN Clinical, a market-leader in the healthcare arena and one of the largest data-focused specialty contract research companies in Europe. For 25 years, SQN Clinical has successfully supported the needs of global pharmaceutical, biotechnology, medical device, and animal health partners. reporting. The acquisition adds more than 100 professionals, increasing Veristat’s European footprint and bolstering one of Veristat’s most sought after service areas, solidifying its position as a premier provider of world class biometrics solutions.
Revenue Cycle Management
Deal
Q1
2021
MedData has announced the acquisition of RevClaims, a Jackson, Mississippi-based outsourced RCM company specializing in third party liability, motor vehicle accidents, Workers’ Compensation, and Veterans Administration billing. Founded in 2005, RevClaims provides high-quality revenue cycle management services to hospitals and health systems primarily in the Southeast and Eastern part of the country.
Diagnostics
Deal
Q1
2021
Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring services (IONM), is pleased to announce that effective February 24, 2021, it has signed a Term Sheet (“Term Sheet”) to acquire (the “Acquisition”) Sentry Neuromonitoring, LLC (“Sentry”), one of the largest IONM service providers in Texas, for a purchase price of $3,500,000. The purchase price to be paid is $1,225,000 in cash and $2,275,000 in Assure common stock, subject to escrow, TSX Venture Exchange and other requirements.
Digital Health / Health Tech
Deal
Q1
2021
CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, announced that it has also acquired TX Services, LLC, provider of TX Connect, as part of its acquisition of TransChart in January 2021. TX Connect is a cloud-based service that allows nephrologists and dialysis centers to electronically submit referrals to transplant programs, closely follow and assist patients through the transplant waitlist process, and ultimately, through transplantation.
Digital Health / Health Tech
Deal
Q1
2021
Thorne, a health and technology company seeking to disrupt the prevention and wellness market, today announced it has merged with Onegevity, a health intelligence company with a proprietary, multi-omic platform that leverages artificial intelligence (AI) and machine learning to map, integrate, and understand the billions of dynamic and biological features that showcase the state of an individual's health. The merger of Thorne and Onegevity creates Thorne HealthTech, a science-driven, vertically integrated wellness platform built to deliver best-in-class, end-to-end nutritional solutions and health intelligence. Thorne HealthTech will be the new parent company of Thorne and Onegevity.
Health Plans
Deal
Q1
2021
The Department of Financial Services (DFS) announced Wednesday it has approved Highmark Inc. and Highmark Health’s application to affiliate with HealthNow New York Inc., a New York not-for-profit Article 43 organization (BlueCross BlueShield of Western New York and BlueShield of Northeastern New York), following an extensive review of the application by DFS in collaboration with the New York State Department of Health. DFS approved the affiliation subject to a number of conditions to which Highmark and HealthNow have agreed, including employee protections and a $10 million commitment to improve racial and health inequities in Western New York and Northeastern New York.
Pharmaceuticals & Biopharmaceuticals
Deal
Q1
2021
Viracta Therapeutics, Inc. (Nasdaq: VIRX), a precision oncology company targeting virus-associated malignancies, announced Wednesday the closing of its merger with Sunesis Pharmaceuticals, Inc. (previously trading on Nasdaq under "SNSS"). The combined, publicly traded company will focus on the advancement and expansion of Viracta's clinical stage pipeline, including Viracta's lead program for the treatment of Epstein-Barr virus (EBV)-positive lymphoma. Shares of the combined company, which is operating under the name Viracta Therapeutics, Inc., will commence trading on the Nasdaq Global Select Market under the ticker symbol "VIRX" on February 25, 2021.
Life Sciences
Deal
Q1
2021
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Pandion Therapeutics, Inc. (Nasdaq: PAND) today announced that the companies have entered into a definitive agreement, under which Merck, through a subsidiary, will acquire Pandion, a clinical-stage biotechnology company developing novel therapeutics designed to address the unmet needs of patients living with autoimmune diseases, for $60 per share in cash. This represents an approximate total equity value of $1.85 billion.
Medical Devices
Deal
Q1
2021
NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced Wednesday that it has acquired Simplify Medical, a privately held company and developer of the Simplify® Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR). The acquisition of Simplify Medical adds the most clinically effective cTDR technology and further distinguishes NuVasive's cervical portfolio in the market.
Medical Devices
Deal
Q1
2021
Siemens Healthineers has scored regulatory approval for its $16.4 billion (USD) acquisition of Varian Medical Systems, government officials announced. The European Commission’s blessing is contingent on the German-based imaging giant promising to make its equipment work with rival products in exchange for the determination.
Real Estate Investment Trust
Deal
Q1
2021
JLL Income Property Trust, an institutionally managed daily NAV REIT with more than $3.5 billion in portfolio assets and 85 properties, announced Wednesday the acquisition of 170 Park Avenue, a 147,000-square-foot, world-class, purpose-built life sciences building in Florham Park, New Jersey. The property is net-leased on a long-term basis as premier laboratory space and the corporate headquarters for Celularity Inc., a clinical-stage biotechnology company. The purchase price was approximately $47 million.
Digital Health / Health Tech
Notable Developments
Q1
2021
The use of digital technologies has accelerated almost overnight due to the COVID-19 pandemic, with healthcare providers and patients finding new and innovative, socially-distanced ways to deliver and receive services. This article explores the current digital health landscape, assesses its benefits, discusses some challenges to its continued widespread adoption, and addresses what is on the horizon for digital healthcare.
Healthcare Investors / Advisors
Notable Developments
Q1
2021
Despite the pandemic’s impact, the volume of healthcare private equity transactions accelerated in the latter half of 2020. Now in a new year with a new administration, investors should expect both new opportunities and challenges to emerge in the healthcare sector. To help navigate the evolving landscape, McDermott Will & Emery is dedicating a series of podcast episodes to healthcare private equity. In this first installment, McDermott Partner Krist Werling talks with Brian Fortune, Senior Director at Farragut Square Group, about the top priorities private equity investors should focus on under the Biden administration.
Otolaryngology
Notable Developments
Q1
2021
Elevate ENT Partners announced Wednesday the launch of its new management service organization platform. Formed by the physician-led leadership team of South Florida ENT Associates, with investment from Audax Private Equity (“Audax”), Elevate ENT Partners invests in private ENT and allergy practices across the United States and provides scalable administrative assistance that removes barriers to quality care and enables practitioners to achieve their professional and financial goals. The new platform ­creates a leading management support organization in the otolaryngology, otology, laryngology, and neuro-otology fields, with nearly 1,000 employees across 60 locations.
Behavioral Health
Notable Developments
Q1
2021
Study after study has shown that behavioral health treatment leads to better overall health outcomes and lower total care costs. But typical fee-for-service reimbursement models don’t account for services’ long-term impact. As such, most behavioral health providers grapple with meager reimbursement rates and slim margins. But the coronavirus could finally change that, mainstreaming value-based care once and for all.
Healthcare Staffing & Education
Notable Developments
Q1
2021
The impact of COVID-19 on front-line healthcare staff will likely be felt for years, and the findings from a recent survey of physicians bring up a key question: is the healthcare industry on the verge of a physician turnover epidemic? The survey, conducted by Jackson Physician Search, a national physician recruitment firm, included responses from 400 physicians across a range of specialties, and from 86 healthcare administrators from throughout the U.S. The study revealed several insightful findings.
Hospitals & Health Systems
Notable Developments
Q1
2021
Down East Community Hospital in Machias said that it plans to purchase the only other hospital in Washington County, Calais Regional Hospital, which has been in bankruptcy since 2019. Calais Regional Hospital, which would become Calais Community Hospital under the new ownership, filed for Chapter 11 bankruptcy in 2019 after several years of operating in the red. Down East had been looking to purchase Calais Regional for several months, the Machias hospital said Friday in announcing its intention to purchase the Calais hospital.
Industry Trends
Regulatory
Q1
2021
False Claims Act (FCA) civil fraud recoveries in Fiscal Year (FY) 2020 dropped over US$850 million when compared to those in FY 2019. While the more than US$2.2 billion in recoveries in FY 2020 continued a general downward trend in FCA civil fraud recoveries since 2016, the past year’s recovery total was likely affected negatively by the global COVID-19 pandemic. The FY 2020 recoveries also do not represent significant actual or pending recoveries totaling over US$3.3 billion. Given these large, pending recoveries and the nation’s potential emergence from the pandemic during the course of 2021, it is highly likely that FY 2020 will be an outlier, while FY 2021 may prove to be an exceptionally high year in terms of FCA recoveries.
Hospitals & Health Systems
Regulatory
Q1
2021
Hospitals increased their Medicare billing for the most severe inpatient stays, sparking concerns from a federal watchdog that facilities could be improperly charging the federal government. The Department of Health and Human Services’ (HHS') Office of Inspector General (OIG) released a report Wednesday (PDF) that explored payments for severe inpatient stays from federal fiscal 2014 through 2019. The HHS watchdog found that stays at the highest severity level are susceptible to inappropriate billing practices such as upcoding.
Health Plans
Deal
Q1
2021
CVC Capital Partners ("CVC") announced Tuesday that CVC Fund VII has signed a definitive agreement to acquire a majority interest in MedRisk ("MedRisk" or “the Company”). MedRisk is a leading provider of managed physical medicine services for the workers’ compensation industry in the U.S. The Carlyle Group, MedRisk’s current majority owner, will retain a significant stake and maintain joint control in partnership with CVC. Founded in 1994 and headquartered in King of Prussia, Pennsylvania, MedRisk consistently delivers clinically superior patient outcomes via the coordination and active management of physical medicine services for workers' compensation patients.
Ophthalmology
Deal
Q1
2021
Sunvera Group (“Sunvera”), a management services organization providing services to ophthalmology practices across multiple subspecialties, announced the addition of Kellis Eye & Laser Center (“Kellis Eye”) to its platform and welcomes Dr. Augustine Kellis to the growing team of eye care specialists. Kellis Eye & Laser is headquartered in Chardon, Ohio, and serves six satellite locations across the greater Cleveland area. With more than 25 years of experience, Dr. Kellis and his team are the premier oculoplastic surgical providers in Ohio. Sunvera Group is a portfolio company of Ridgemont Equity Partners.
Hospitals & Health Systems
Deal
Q1
2021
After years of on-and-off discussions, Rhode Island's two most dominant healthcare organizations announced on Tuesday that they have signed a merger agreement that includes a collaboration with Brown University's medical school to create an integrated statewide healthcare system. The merger of Lifespan and Care New England will improve patient access and care, address racial and ethnic disparities in care, foster research and innovation, and help drive the state economy, among other benefits, the organizations said in a statement. Brown's Warren Alpert Medical School has committed to providing a minimum of $125 million over five years in support of the endeavor.
Behavioral Health, Healthcare Information Technology
Deal
Q1
2021
CentralReach, the leading provider of electronic medical record (EMR), practice management, and clinical solutions that enable Applied Behavior Analysis (ABA) and related behavioral health practices to deliver quality autism care for superior outcomes, announced Tuesday the acquisition of Irish-based Avail Support Limited, an award-winning provider of evidence-based digital content management and data collection solutions serving the education, employment support services, and adult transition services markets.
Business Services, Dental
Deal
Q1
2021
RevenueWell, the Chicago-based developer of Dental Patient Relationship Management and Communication software, announced Tuesday it has completed its acquisition of PBHS, the ADA Endorsed leader in digital marketing for dental and dental specialty practices. PBHS’s services include dental website design, practice branding, SEO, online advertising, video marketing and social media campaigns. The investment furthers RevenueWell’s mission to deliver a unified, integrated practice-growth solution to simplify patient acquisition and retention for dental practices ranging from solo practices to enterprise-level group practices and Dental Service Organizations (DSOs).
Contract Research Organizations
Deal
Q1
2021
ICON plc, (NASDAQ: ICLR), a global provider of outsourced drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, and government and public health organisations, today announced it has entered into a definitive agreement to acquire PRA Health Sciences, Inc. (NASDAQ: PRAH) in a cash and stock transaction valued at approximately $12 billion, with the per share merger consideration consisting of $80 in cash and 0.4125 shares of ICON stock. The consideration represents an approximately 30% premium to PRA’s closing price as of February 23rd, 2021.
Digital Health / Health Tech
Deal
Q1
2021
Healthcare Bluebook, an industry leader in delivering clear and actionable healthcare quality and cost information, today announced it has acquired the Quality division of Quantros, Inc., a leading provider of quality analytics software for healthcare providers and payors. With the acquisition, Bluebook enhances the breadth and quality of its healthcare data, enhances existing analytics capabilities, and positions the combined organization to reach a wider range of customers, including value-focused hospitals, health systems, and select payors.
Digital Health / Health Tech
Deal
Q1
2021
Terumo Corporation (TSE: 4543), a global leader in medical technology, has signed a definitive agreement to acquire all assets of Health Outcomes Sciences, Inc. (HOS). HOS specializes in predictive analytics and clinical decision support that enable healthcare organizations to deliver personalized, predictive insights at the point of care, resulting in significant and measurable improvements in clinical, patient and financial outcomes.
Healthcare Supplies & Suppliers
Deal
Q1
2021
Probo Medical (“Probo”), a leading global provider of medical imaging equipment, parts, repair and service, announced today the acquisition of IMAX Medical (“IMAX”). Terms of the transactions were not disclosed. IMAX, founded by Patrick Roussel in 2012, is a Nantes, France based company specializing in the purchasing, sales and logistics of pre-owned medical diagnostic imaging equipment. IMAX is led today by Simon Roussel and supported by a team of medical equipment professional with deep experience in both the French and European markets. Probo Medical is backed by Varsity Healthcare Partners.
Assisted Living
Deal
Q1
2021
Transforming Age and Sustainable Housing for Ageless Generations (SHAG) are affiliating and intend to leverage their combined resources to expand further into middle-market senior housing and pursue other strategic objectives. Both organizations are based near Seattle, and the combination with SHAG makes Transforming Age the eighth-largest nonprofit senior living provider in the United States, serving more than 14,000 people across its various service lines, including more than 50 senior housing communities across the continuum of care, according to Tuesday’s announcement of the affiliation.
Medical Devices
Deal
Q1
2021
Detroit-based MRI technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations). The acquisition brings an expert team of PhD and master's-level engineers and physicists and also includes MR Innovations' 10 patents, over 300 published papers and a network of more than 50 global collaborators.
Real Estate Investment Trust
Deal
Q1
2021
Artemis Real Estate Partners acquired a 10-property medical office building portfolio across six states, REjournals reported Feb. 19. Around 50 percent of the buildings are leased to health systems and several physician groups. Some of the medical office buildings also include imaging centers, ASCs and cancer centers.
Digital Health / Health Tech
Notable Developments
Q1
2021
Private equity deal volume hit a low in the first half of 2020 as the pandemic slowed the US and global economies. But toward the end of the year, deals began picking back up, particularly in the digital health space. COVID-19 forced healthcare providers to shift from in-person to virtual care, and technology was the vehicle to make that switch possible. Investors noticed, and more deals focused on companies specializing in telehealth, remote patient monitoring and other technology platforms that facilitate communication among specialists. Expect this trend to continue in 2021, and keep these three factors in mind when evaluating the digital health landscape.
Animal Health
Notable Developments
Q1
2021
BluePearl Specialty and Emergency Pet Hospital, a national provider of advanced veterinary care, serving more than one million pets each year, released its first-ever Pet Owner and Veterinarian Reports, entitled People and Pets in the Pandemic and Changes, Challenges, and the Coronavirus, respectively. The reports identify how the pandemic has prompted a surge in pet ownership, strengthened the human-animal bond, and posed challenges to the process of providing pet care. Among the key findings in the 2020 Veterinarian Report was a marked increase in the number of pets seen at veterinary practices across the U.S.
Behavioral Health
Notable Developments
Q1
2021
New poll results from the American Psychological Association (APA) shows that adults in the US are experiencing the highest levels of stress since the pandemic began. This prolonged and elevated stress is fueling increased demand for mental health services. To meet this increased demand for mental health services, providers are turning to new technologies and new delivery models. Healthcare IT Today reached out to one company that is doing some interesting work in this area – AbleTo – to find out more about their hybrid electronic Cognitive Behavior Therapy (CBT) and live therapist solution.
Surgical Centers / Facilities and Practices
Notable Developments
Q1
2021
ASCs in California are thriving, with new development growing to meet demand of the state's population. Here, Elizabeth LaBouyer, RN, executive director of the California Ambulatory Surgery Association, and Adela Simon, administrator at Carrillo Surgery Center in Santa Barbara, discussed the state of ASCs in California and where the industry is going in 2021.
Home Health & Hospice
Notable Developments
Q1
2021
The Pennant Group (NASDAQ: PNTG) has increased its revolving line of credit by $75 million to a total $150 million. The company indicated the bulk of the additional credit would be used for acquisitions, including hospice and home health assets. Pennant invested heavily in the growth of its hospice business during 2020, with two start-up locations and four hospice acquisitions.
Behavioral Health, Digital Health / Health Tech
Notable Developments
Q1
2021
Life Clips, Inc. (OTC Pink: LCLP) (the “Company”), today announced that it has entered into a letter of intent to acquire Cognitive Apps Software Solutions Inc., a developer of artificial intelligence (AI) applications for the healthcare industry and psychedelic research. Cognitive Apps provides an AI powered mental health analytics platform empowering businesses to measure, understand, and improve mental well-being of their employees, patients or customers with easy to use tools.
Home Health & Hospice
Regulatory
Q1
2021
When a public health emergency was declared last March, the Centers for Medicare & Medicaid Services (CMS) issued a variety of waivers allowing home health providers to more easily provide telehealth services during the crisis. Now, the Office of Inspector General (OIG) has announced an audit, dubbed the “HHA Telehealth Project,” that will examine home health providers’ usage of telehealth over the last year while the flexibilities were granted. The audit will take aim at evaluating the home health services provided by deciphering whether agencies administered and billed for services in an appropriate manner.
Home Health & Hospice
Regulatory
Q1
2021
The U.S. Supreme Court has declined to hear arguments in a False Claims Act (FCA) case involving the hospice provider Care Alternatives. FCA actions pertaining to hospices most commonly focus on questions of a patient’s eligibility for those services. In the case, United States ex rel. Druding v. Care Alternatives, the Third Circuit Court of Appeals ruled that when a reasonable difference of opinion occurs between physicians concerning a hospice patient’s prognosis, it can be resolved by a jury.
Dental
Deal
Q1
2021
Sage Dental, a leading dental service organization committed to providing consistent, high-quality care, as well as non-clinical business and administrative services to affiliated practices, today announced the acquisition of six new dental practices in south Florida, expanding the total number of locations to over 65. In addition to the six new practices, the company is also pleased to welcome two new hires to the Sage Dental Management executive team, who will help lead the company’s continued expansion in the years ahead.
Digital Health / Health Tech
Deal
Q1
2021
Sharecare, the digital health company that helps people manage all their health in one place, today announced it has completed its acquisition of doc.ai, an enterprise artificial intelligence (AI) platform accelerating digital transformation in healthcare, as announced on January 28, 2021. Doc.ai co-founders Sam De Brouwer and Walter De Brouwer have been named Sharecare's new chief strategy officer and chief scientific officer, respectively. Other members of the doc.ai senior management team also have joined Sharecare's leadership team, including Nirav Shah as the company's new chief medical officer and Akshay Sharma, who serves as executive vice president of artificial intelligence.
Healthcare Staffing & Education, Pharmaceuticals & Biopharmaceuticals
Deal
Q1
2021
NovaQuest Private Equity (“NovaQuest”) today announced its strategic growth equity investment in Pro-ficiency, LLC (“Pro-ficiency”), a leading provider of tech-enabled training and compliance solutions for clinical trial investigators and site staff. Based in Durham, NC, Pro-ficiency provides innovative, virtual simulation training and HR compliance solutions for clinical trials, supported by original content creation and analytics services. Leading pharmaceutical companies engage Pro-ficiency to deploy customized, study-specific training solutions that improve learning retention and strengthen compliance among investigators and site staff.
Contract Research Organizations
Deal
Q1
2021
Novo Holdings A/S, a world-leading life science investor with a focus on long-term, sustainable value creation, announced Monday that it has agreed to acquire Altasciences from Audax Private Equity. Founded in 1992, Altasciences is a leading, fully-integrated, early drug development services platform, providing the pharma and biotech industries with a trusted partner for drug development, from preclinical safety testing through clinical proof-of-concept studies. In the past decade, the company has grown both organically and through acquisitions to have a significant presence in the preclinical safety testing, clinical pharmacology, bioanalytical, CRO services, and CDMO markets.
Contract Manufacturing Organizations
Deal
Q1
2021
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Delphi Genetics, a plasmid DNA (pDNA) cell and gene therapy contract development and manufacturing organization (CDMO) based in Gosselies, Belgium, today announced that they have entered into a final and definitive agreement whereby Catalent will acquire 100% of the shares of Delphi Genetics. Catalent is also announcing the launch of pDNA development and manufacturing services at its Rockville, Maryland facility.
Diagnostics
Deal
Q1
2021
Hologic, Inc. (Nasdaq: HOLX), a global leader in women's health, has completed its previously announced acquisition of molecular oncology leader Biotheranostics, Inc. for approximately $230 million. Biotheranostics develops and markets two highly differentiated molecular diagnostic tests for breast and metastatic cancers – Breast Cancer Index™ (BCI) and CancerTYPE ID® (CTID).